Application of nucleoside pharmaceutical intermediates
On July 25, 2022, the State Food and Drug Administration approved the application for registration of new indications for the treatment of coronavirus pneumonia with Azovudine under emergency conditions for the treatment of adult patients with common new coronavirus pneumonia (COVID-19). ...
危险品化学品经营许可证（带存储）